Pulmonx (LUNG) Notes Payables (2019 - 2025)
Historic Notes Payables for Pulmonx (LUNG) over the last 7 years, with Q3 2025 value amounting to $105000.0.
- Pulmonx's Notes Payables rose 606.06% to $105000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $105000.0, marking a year-over-year increase of 606.06%. This contributed to the annual value of $3.2 million for FY2024, which is 4737.82% up from last year.
- Latest data reveals that Pulmonx reported Notes Payables of $105000.0 as of Q3 2025, which was up 606.06% from $104000.0 recorded in Q2 2025.
- Over the past 5 years, Pulmonx's Notes Payables peaked at $17.3 million during Q4 2021, and registered a low of $90000.0 during Q4 2022.
- Its 5-year average for Notes Payables is $4.7 million, with a median of $2.2 million in 2023.
- In the last 5 years, Pulmonx's Notes Payables crashed by 9948.05% in 2022 and then skyrocketed by 564835.16% in 2024.
- Over the past 5 years, Pulmonx's Notes Payables (Quarter) stood at $17.3 million in 2021, then tumbled by 99.48% to $90000.0 in 2022, then surged by 2294.44% to $2.2 million in 2023, then surged by 47.38% to $3.2 million in 2024, then tumbled by 96.69% to $105000.0 in 2025.
- Its last three reported values are $105000.0 in Q3 2025, $104000.0 for Q2 2025, and $7.8 million during Q1 2025.